Instrument Inactif

Autres langues 3Legs Resources plc London S.E.

Actions

IM00B52P5P72

Recherche biotechnologique et médicale

Cours en clôture London S.E. Autres places de cotation
- ^GBX	-

Autres langues

14/10/20	SalvaRx : Portage Issues Common Shares and Warrants in Settlement of SalvaRx Loan Note Obligations
27/09/19	SalvaRx : Half Yearly Report 30 June 2019 RNS
26/09/19	SalvaRx : RNS SalvaRx Group PLC interim report 30 June 2019
26/09/19	SalvaRx Evaluates Takeover Opportunities
26/09/19	Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019
28/06/19	Salvarx Group plc Reports Earnings Results for the Full Year Ended December 31, 2018
08/01/19	Portage Biotech Inc. (OTCPK:PTGE.F) completed the acquisition of SalvaRx Limited from SalvaRx Group plc, James Mellon and Greg Baile.
27/09/18	SalvaRx Group plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018
14/08/18	Portage Biotech Inc. (OTCPK:PTGE.F) (‘Portage’) entered into a conditional sale agreement to acquire SalvaRx Limited from SalvaRx Group plc, James Mellon and Greg Baile for $80.5 million.
28/06/18	SalvaRx Group plc Announces Consolidated Earnings Results for the Year Ended December 31, 2017
28/06/18	SalvaRx Seeks Acquisitions
26/06/18	SalvaRx Announces an Unsecured $1 Million Loan
27/09/17	SalvaRx Group plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017
30/06/17	SalvaRx Group plc Announces Final Audited Consolidated Earnings Results for the Year Ended December 31, 2016
30/06/17	SalvaRx Seeks Investments
30/05/17	SalvaRx Group plc Treats First Patient INT230-6 as Part of A Phase 1/2 International Clinical Study
13/09/16	SalvaRx Group plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016
27/06/16	Salvarx Group plc Announces Audited Consolidated Earnings Results for the Year Ended 31 December 2015
27/06/16	SalvaRx Seeks Acquisitions
26/06/16	Intensity Therapeutics, Inc. announced that it has received $10 million in funding from Batterson Venture Capital, LLC, Vcapital, Inc., Seed Innovations Limited, SalvaRx Group plc
22/03/16	SalvaRx Limited completed the acquisition of 3Legs Resources plc from BlackRock Investment Management (UK) Limited, British Polar Engines Ltd., Pires Investments PLC, Port Erin Biopharma Investments Limited and other shareholders in a reverse merger transaction.
04/11/15	SalvaRx Limited signed non-binding heads of terms to acquire 3Legs Resources plc from BlackRock Investment Management (UK) Limited, British Polar Engines Ltd., Pires Investments PLC, Port Erin Biopharma Investments Limited and other shareholders in a reverse merger transaction.
30/09/15	SalvaRx Limited announced that it has received £0.43 million in funding from 3Legs Resources plc and other investors.